Getting to Know Dr Doug Marks, Oncology Clinical Trialist

Throughout February, The American Journal of Managed Care^® will be introducing its audience to the next generation of great thinkers and groundbreakers in health care. They represent the fields of oncology, public health, and managed care and are fast making their marks as key opinion leaders in their fields.

Douglas K. Marks, MD, is a breast medical oncologist and director of the Clinical Trials Office, Perlmutter Cancer Center, NYU Langone Hospital—Long Island, and associate professor in the Department of Medicine at NYU Grossman Long Island School of Medicine in New York City. As a phase 1 clinical trialist, he sees both patients with breast cancer and those whose disease has already been treated but who are looking to receive innovative treatments for their early-stage disease.

“I've really enjoyed working with oncologists treating all types of different cancers, to similarly empower them to have the trials that they need for their patients,” Marks emphasizes. “And personally, as someone who is from Long Island, recognizing that the need is very high on Long Island—when you look at percentages of breast cancer incidence, we’re very high in the country—and helping to bring clinical trials. Also just helping to bring high-quality subspecialty breast cancer care to people's home communities.”

We hope you enjoy discovering more about Marks, his efforts to meet the great need for top-notch breast cancer care in his backyard, the goals he has set for himself and his patients, and why he believes it is important to have both clinical and academic career interests to excel and make a difference.

For the first interview in this series, with Chandler Cortina, MD, MS, FSSO, FACS, assistant professor of surgery and breast surgical oncologist at Froedtert & Medical College of Wisconsin, Milwaukee, please click here.